4D Molecular Therapeutics, Inc. (FDMT)
10.80
-1.05
(-8.86%)
USD |
NASDAQ |
Oct 23, 16:00
10.78
-0.02
(-0.23%)
After-Hours: 20:00
4D Molecular Therapeutics Price to Book Value : 1.463 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.463 |
| October 22, 2026 | 1.605 |
| October 21, 2026 | 1.709 |
| October 20, 2026 | 1.774 |
| October 19, 2026 | 1.665 |
| October 16, 2026 | 1.644 |
| October 15, 2026 | 1.743 |
| October 14, 2026 | 1.652 |
| October 13, 2026 | 1.674 |
| October 12, 2026 | 1.761 |
| October 09, 2026 | 1.805 |
| October 08, 2026 | 1.720 |
| October 07, 2026 | 1.705 |
| October 06, 2026 | 1.701 |
| October 05, 2026 | 1.750 |
| October 02, 2026 | 1.852 |
| October 01, 2026 | 1.874 |
| September 30, 2026 | 1.938 |
| September 29, 2026 | 1.963 |
| September 28, 2026 | 1.972 |
| September 25, 2026 | 1.960 |
| September 24, 2026 | 1.992 |
| September 23, 2026 | 2.032 |
| September 22, 2026 | 2.151 |
| September 21, 2026 | 2.064 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.061 |
| September 17, 2026 | 1.988 |
| September 16, 2026 | 1.864 |
| September 15, 2026 | 1.846 |
| September 14, 2026 | 1.864 |
| September 11, 2026 | 1.784 |
| September 10, 2026 | 1.827 |
| September 09, 2026 | 1.921 |
| September 08, 2026 | 1.982 |
| September 04, 2026 | 2.028 |
| September 03, 2026 | 1.991 |
| September 02, 2026 | 2.024 |
| September 01, 2026 | 1.944 |
| August 31, 2026 | 1.911 |
| August 28, 2026 | 1.987 |
| August 27, 2026 | 2.019 |
| August 26, 2026 | 2.108 |
| August 25, 2026 | 2.129 |
| August 24, 2026 | 2.084 |
| August 21, 2026 | 2.144 |
| August 20, 2026 | 2.181 |
| August 19, 2026 | 2.27 |
| August 18, 2026 | 1.994 |
| August 17, 2026 | 1.97 |
| August 14, 2026 | 1.651 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| PS Ratio | 7.397 |
| Price | 10.80 |
| Earnings Yield | -25.23% |
| Market Cap | 596.31M |